This blog post discusses the article "Changing Interactions Between Physician Trainees and the Pharmaceutical Industry” published in the February 27, 2013 electronic edition of the Journal of General Internal Medicine. The study was conducted by former Fellow in the Lab on Institutional Corruption Kirsten Austad, Lab affiliates Aaron Kesselheim M.D. J.D. and Eric Campbell Ph.D., and Jerry Avorn M.D. and other members of the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital and Harvard Medical School.
Within a week of its online-first publication the article received worldwide coverage, including The Boston Globe, Stuttgarter Zeitung, Popular Science, Pharmalot, HealthDay (in English and Spanish), and a host of medical and legal themed news portals and blogs.
- WP 01. March 15, 2013. Lawrence Lessig, Institutional Corruptions.
- WP 02. March 21, 2013. Donald W. Light, Strengthening the Theory of Institutional Corruptions: Broadening, Clarifying, and Measuring.
- WP 03. March 28, 2013. Brooke Williams, Influence Incognito.
- WP 04. April 4, 2013. Maryam Kouchaki, Professionalism and Moral Behavior: Does A Professional Self-Conception Make One More Unethical?
- WP 05. April 11, 2013. Malcolm S. Salter, Short-Termism At Its Worst: How Short-Termism Invites Corruption... and What to Do About It.
- WP 06. April 18, 2013. Gregg Fields, What Institutional Corruption Shares with Obscenity.
- WP 07. April 25, 2013. Jay Youngdahl, Investment Consultants and Institutional Corruption.
- WP 08. May 2, 2013. Miriam Schwartz-Ziv, Does the Gender of Directors Matter?
- WP 09. May 9, 2013. Lisa Cosgrove and Robert Whitaker, Finding Solutions to Institutional Corruption: Lessons from Cognitive Dissonance Theory.
- WP 10. May 16, 2013. Daniel Weeks, Democracy in Poverty: A View from Below.
For more on this series, go to Tools